Fluvastatin in the first-line therapy of acute coronary syndrome: results of the multicenter, randomized, double-blind, placebo-controlled trial (the FACS-trial)

BACKGROUND: Statins have been proved to be effective in reduction of mortality and morbidity when started in the early secondary prevention in stabilized patients after acute coronary syndrome (ACS). The safety and efficacy of statin administration directly in the first-line therapy in unstable ACS...

Descripción completa

Detalles Bibliográficos
Autores principales: Ostadal, Petr, Alan, David, Vejvoda, Jiri, Kukacka, Jiri, Macek, Milan, Hajek, Petr, Mates, Martin, Kvapil, Milan, Kettner, Jiri, Wiendl, Martin, Aschermann, Ondrej, Slaby, Josef, Holm, Frantisek, Telekes, Peter, Horak, David, Blasko, Peter, Zemanek, David, Veselka, Josef, Cepova, Jana
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2886041/
https://www.ncbi.nlm.nih.gov/pubmed/20500832
http://dx.doi.org/10.1186/1745-6215-11-61

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2886041/
https://www.ncbi.nlm.nih.gov/pubmed/20500832
http://dx.doi.org/10.1186/1745-6215-11-61

Ejemplares similares